{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:53:33Z","timestamp":1761580413687},"reference-count":31,"publisher":"American Physiological Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Heart and Circulatory Physiology"],"published-print":{"date-parts":[[2006,11]]},"abstract":"<jats:p> Sympathetic vasoconstriction is susceptible to diabetes, but contributions made by purinergic neurotransmission in this state have not been investigated. We aimed to evaluate sympathetic vasoconstriction contributions by ATP and norepinephrine in the tail artery from streptozotocin-diabetic rats by using isometric vascular rings. Tail arteries were isolated from rats made diabetic 3 mo earlier with streptozotocin (diabetic group), age-matched nondiabetic rats (nondiabetic injected), age-matched untreated animals (noninjected normal), and age-matched untreated animals in high glucose control Krebs solution (high glucose control). Responses to KCl (60 mM) or nerve stimulus trains of 1\u2013100 impulses were identical in all groups. Electrical stimulation produced progressively greater contractions with increasing impulse numbers. These were partially reduced by suramin (100 \u03bcM, P2 antagonist), NF-279 (1 \u03bcM, P2X blocker), and phentolamine (2 \u03bcM, \u03b1-blocker). For purinergic antagonists, blockade was greater in diabetic vessels compared with that in others. No differential effect could be detected for phentolamine between groups. Bath-applied ATP (1 nM\u20131 mM) and norepinephrine (0.1 nM\u2013100 \u03bcM) showed increased potency with diabetic group vessels. Desipramine (1 \u03bcM, norepinephrine reuptake inhibitor) potentiated neurally evoked responses in all groups equally and increased sensitivity to exogenous norepinephrine in a similar fashion. Histochemical labeling of sympathetic nerves with neuronal marker protein PGP-9.5 and a sympathetic nerve-specific antibody for tyrosine hydroxylase showed no reduction in diabetic innervation density. We demonstrate, for the first time, changes in contributions of ATP and norepinephrine in sympathetic responses of rat tail artery in diabetes, which cannot be accounted for by axonal degeneration or by changes in norepinephrine reuptake. <\/jats:p>","DOI":"10.1152\/ajpheart.01298.2005","type":"journal-article","created":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T04:22:08Z","timestamp":1151727728000},"page":"H2327-H2333","source":"Crossref","is-referenced-by-count":16,"title":["ATP and norepinephrine contributions to sympathetic vasoconstriction of tail artery are altered in streptozotocin-diabetic rats"],"prefix":"10.1152","volume":"291","author":[{"given":"Lynne","family":"Speirs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisling","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Norman","family":"Scholfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"24","reference":[{"key":"R1","unstructured":"Bao JX. Sympathetic neuromuscular transmission in rat tail artery: a study based on electrochemical, electrophysiological and mechanical recording. Acta Physiol Scand Suppl 610: 1\u201358, 1993."},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1993.tb09648.x"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1993.tb13979.x"},{"key":"R4","unstructured":"Bennett T. Physiological investigation of diabetic autonomic failure. In: Autonomic Failure, edited by Banister R. Oxford, Oxford University Press, 1983, p. 403\u2013406."},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01061.2002"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(90)93450-5"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704221"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1990.259.1.H55"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1007\/BF00493242"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Curtis TM, Major EH, Trimble ER, and Scholfield CN. Diabetes-induced activation of protein kinase C inhibits store-operated Ca2+ uptake in rat retinal microvascular smooth muscle. Diabetologia 46: 1252\u20131259, 2000.","DOI":"10.1007\/s00125-003-1178-5"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00316-1"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000146272.80848.37"},{"key":"R13","unstructured":"Donnelly A, Roe S, Scholfield CN, and Johnson CD. Altered cotransmitter contributions to sympathetic vasoconstriction of tail artery in streptozotocin diabetic rats. J Physiol 555P: C36, 2004."},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1994.tb17071.x"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703760"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1838(88)90007-0"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.2001.281.6.H2432"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1992.tb14257.x"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1177\/153537020122601010"},{"key":"R20","unstructured":"Morris JL and Gibbins IL. Cotransmission and neuromodulation. In: Autonomic Neuroeffector Mechanisms, edited by Burnstock G and Hoyle CHV. Amsterdam, The Netherlands: Harwood Academic, 1992, p. 33\u2013119."},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1993.tb13928.x"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(95)00451-P"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1990.tb08880.x"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)90280-1"},{"key":"R25","unstructured":"Takiguchi Y, Satoh N, Hasimoto H, and Nakashima M. Changes in vascular reactivity in experimental diabetic rats: comparison with hypothyroid rats. Blood Vessels 25: 250\u2013260, 1989."},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(96)88533-6"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00009-1"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.2000.278.3.H714"},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1996.tb15373.x"},{"key":"R30","unstructured":"Weber LP and MacLeod K. Influence of streptozotocin diabetes on the alpha-1 adrenoceptor responses and associated G proteins in rat arteries. J Pharmacol Exp Ther 283: 1469\u20131478, 1997."},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1988.255.5.H1036"}],"container-title":["American Journal of Physiology-Heart and Circulatory Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/ajpheart.01298.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T20:25:10Z","timestamp":1567974310000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/ajpheart.01298.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["10.1152\/ajpheart.01298.2005"],"URL":"https:\/\/doi.org\/10.1152\/ajpheart.01298.2005","relation":{},"ISSN":["0363-6135","1522-1539"],"issn-type":[{"value":"0363-6135","type":"print"},{"value":"1522-1539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}